Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

aTyr Pharma Inc sell nvestor

Start price
€3.78
12.12.20 / 50%
Target price
€2.00
12.12.21
Performance (%)
-23.28%
Price
€3.02
14.05.21
This prediction is currently active. The prediction for aTyr Pharma Inc shows a convincing performance of -23.28%. This prediction currently runs until 12.12.21. The prediction end date can be changed by nvestor at any time. nvestor has 50% into this prediction

According to nvestor what are the pros and cons of aTyr Pharma Inc for the foreseeable future?

Pros
Cons
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
overvalued
Very low/no dividend yield expected
very negative Cash Flow expected
Junk rating
Very little Investments for future growth
High risks in the balance sheet
ROE lower than 5% per year
High challenges to pay loans and raise capital
Deficits in Management
Very bad culture
No Innovation
Dependend from few customers or products
Growths much slower than the competition
Sustainability is not important
No uniques
Mainly gamblers invest here
High risks for its business
Nicheplayer
Very high cyclical dependencies
Unknown brand
Outdated or very high risk business model

Comments by nvestor for this prediction

In the thread aTyr Pharma Inc diskutieren
Prediction Sell
Perf. (%) -23.28%
Target price 2.000
Change
Ends at

Sell mit Kursziel 2,0